In both the MACRO and STATCOPE cohorts, the patients taking beta-blockers had a higher percentage of patients free of exacerbation though this difference did not reach statistical significance in either group.
← all excerpts
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
1
—
—